Legend: Interesting =number_format($GLOBALS["totscache"]["RateGood"])?> Not Interesting =number_format($GLOBALS["totscache"]["RateBad"])?>
Add Another Tag/Keyword To Link
Test AltBib.Com Backup Copy Report Broken Link and Get Redirected To Backup Copy
In a number of big ways, the offline backup
is far inferior to this online version,
but it is there juuust in case we lose
free speech as we know it on the internet.
DATABASE TOTALS:6,082 Reference Links,
with 11,639 Tags/Keywords,
with 68,035 Taggings
AltBib.Com is a free, research database with articles,
documents and videos shining light on interesting topics.
Most links are to significant information 'validated' as 'true' by the Mainstream Media, sometimes buried in the final paragraphs,
which are directly referenced by the Alternative Media/New Media in creating controversial alternative analysis.
So check out some mainstream evidence and see if you naturally end up agreeing with an alternate analysis.
You can pick a tag/keyword/topic or source from the menus above to start wandering the database,
or make more complicated Custom Filters.
Or use the Search bar to type in tags or news headlines to refine your filter.
Please help this resource grow by suggesting new links, and adding tags to or rating links.
More tools launching soon...
Documents are largely from what is referenced by interesting films, Prison Planet/Infowars and the Corbett Report. This database is a quick reference and for your analysis, more independent from others' interpretations. The database includes almost all source documents and articles from these films: Loose Change (Final Cut & 2nd Edition), Fabled Enemies, The Obama Deception, End Game, Martial Law 9/11, American Dictators, Matrix of Evil, Zeitgeist: Addendum, Who Killed The Electric Car?, The World According To Monsanto, Mind The Gap, and 7/7 Ripple Effect.
U.S. health officials strengthened their recommendations for seasonal flu vaccines on Friday, saying all children aged 6 months to 18 years should be immunized -- especially because of the H1N1 flu pandemic (Reuters)
The federal government should get about 100 million doses of vaccine by mid-October, if the current production by five companies goes as planned (Washington Post)
Scientists debate blending species In Minnesota, pigs are being born with human blood in their veins. In Nevada, there are sheep whose livers and hearts are largely human. In California, mice peer from their cages with human brain cells firing inside their skulls.
These are not outcasts from “The Island of Dr. Moreau,” the 1896 novel by H.G. Wells in which a rogue doctor develops creatures that are part animal and part human. They are real creations of real scientists.
Biologists call these hybrids chimeras, after the mythical Greek creature with a lion’s head, a goat’s body and a serpent’s tail. They are products of experiments in which human stem cells were added to developing animal fetuses.
Chimeras are allowing scientists to watch, for the first time, how nascent human cells and organs mature and interact – not in the cold isolation of laboratory dishes but inside the bodies of living creatures. Some are already revealing deep secrets of human biology and pointing the way toward new medical treatments. (Washington Post)
US Would Close Schools, Restrict Travel In Case of Worldwide Flu Outbreak Among its suggested preparations to limit the spread of infection and care for the ill, the plan stresses major federal research to create "seed strains" of worrisome flu types as potential vaccine candidates. Such work might shave a few months off the typical six to eight months it now takes to brew a new flu vaccine, said Dr. Anthony Fauci, the National Institutes of Health's infectious disease chief. (Associated Press)
The Truth About the Drug Companies Every day Americans are subjected to a barrage of advertising by the pharmaceutical industry. Mixed in with the pitches for a particular drug—usually featuring beautiful people enjoying themselves in the great outdoors—is a more general message. Boiled down to its essentials, it is this: “Yes, prescription drugs are expensive, but that shows how valuable they are. Besides, our research and development costs are enormous, and we need to cover them somehow. As ‘research-based’ companies, we turn out a steady stream of innovative medicines that lengthen life, enhance its quality, and avert more expensive medical care. You are the beneficiaries of this ongoing achievement of the American free enterprise system, so be grateful, quit whining, and pay up.” More prosaically, what the industry is saying is that you get what you pay for.
Is any of this true? Well, the first part certainly is. Prescription drug costs are indeed high—and rising fast. Americans now spend a staggering $200 billion a year on prescription drugs, and that figure is growing at a rate of about 12 percent a year (down from a high of 18 percent in 1999).1 Drugs are the fastest-growing part of the health care bill—which itself is rising at an alarming rate. The increase in drug spending reflects, in almost equal parts, the facts that people are taking a lot more drugs than they used to, that those drugs are more likely to be expensive new ones instead of older, cheaper ones, and that the prices of the most heavily prescribed drugs are routinely jacked up, sometimes several times a year.
Before its patent ran out, for example, the price of Schering-Plough’s top-selling allergy pill, Claritin, was raised thirteen times over five years, for a cumulative increase of more than 50 percent—over four times the rate of general inflation.2 As a spokeswoman for one company explained, “Price increases are not uncommon in the industry and this allows us to be able to invest in R&D.”3 In 2002, the average price of the fifty drugs most used by senior citizens was nearly $1,500 for a year’s supply. (Pricing varies greatly, but this refers to what the companies call the average wholesale price, which is usually pretty close to what an individual without insurance pays at the pharmacy.)
This is an industry that in some ways is like the Wizard of Oz—still full of bluster but now being exposed as something far different from its image. Instead of being an engine of innovation, it is a vast marketing machine. Instead of being a free market success story, it lives off government-funded research and monopoly rights. Yet this industry occupies an essential role in the American health care system, and it performs a valuable function, if not in discovering important new drugs at least in developing them and bringing them to market. But big pharma is extravagantly rewarded for its relatively modest functions. We get nowhere near our money’s worth. The United States can no longer afford it in its present form. (The New York Review of Books)
Edible HIV vaccine breakthrough Maize genetically modified to contain a key protein found on the surface of the monkey form of HIV has been created by US company ProdiGene. This development brings an edible, more effective, HIV vaccine for people a step closer, says the US National Institutes of Health.
The protein
SIV gp120
is the simian form of a protein that will be used in an HIV vaccine trial on people in Thailand later in 2002. Researchers will inject a canarypox virus modified to contain HIV genes and then a booster shot of HIV gp120. Both the trial and ProdiGene's SIV maize research are being funded by the NIH.
But the injected HIV gp120 is not expected to provoke a strong immune response in the mucosal layers of the body, whereas an ingested vaccine would. "For AIDS, a mucosal vaccine is important in two respects," says Stuart Shapiro, of the National Institute for Allergy and Infectious Diseases, NIH, US. (New Scientist)
This database has been loaded 1,796,467 times since May 2009.
FAIR USE NOTICE:
This site contains copyrighted material the use of which has not always been specifically
authorized by the copyright owner. We are making such material available in our efforts to advance
understanding of criminal justice, political, human rights, economic, democracy, scientific, and
social justice issues, etc. We believe this constitutes a 'fair use' of any such copyrighted material
as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107,
the material on this site is distributed without profit to those who have expressed a prior interest in
receiving the included information for research and educational purposes. For more information go to:
http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own
that go beyond 'fair use', you must obtain permission from the copyright owner.